All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAART-LX247 | Anti-β2GPI (Cof-20) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | Cof-20 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX248 | Anti-β2GPI (Cof-22) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | Cof-22 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX249 | Anti-β2GPI (CIC01) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | CIC01 | Human | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX250 | Anti-β2GPI (IS4) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | IS4 | Human | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX251 | Anti-β2GPI (LJB8) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | LJB8 | Human | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX252 | Anti-β2GPI (2C4C2) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | 2C4C2 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX253 | Anti-β2GPI (Cof-20) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | Cof-20 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX254 | Anti-β2GPI (Cof-22) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | Cof-22 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX255 | Anti-β2GPI (CIC01) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | CIC01 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX256 | Anti-β2GPI (IS4) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | IS4 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX257 | Anti-β2GPI (LJB8) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | LJB8 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX258 | Anti-β2GPI (2C4C2) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | 2C4C2 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION